These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9669932)

  • 21. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.
    Laakso MM; Lee FH; Haggarty B; Agrawal C; Nolan KM; Biscone M; Romano J; Jordan AP; Leslie GJ; Meissner EG; Su L; Hoxie JA; Doms RW
    PLoS Pathog; 2007 Aug; 3(8):e117. PubMed ID: 17722977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
    Martín J; LaBranche CC; González-Scarano F
    J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigators detail HIV's fatal handshake.
    Cohen J
    Science; 1996 Oct; 274(5287):502. PubMed ID: 8928003
    [No Abstract]   [Full Text] [Related]  

  • 24. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor.
    Cormier EG; Dragic T
    J Virol; 2002 Sep; 76(17):8953-7. PubMed ID: 12163614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the Physicochemical and Structural Modifications Associated with HIV-1 Subtype B Tropism Transition.
    Lamers SL; Fogel GB; Liu ES; Salemi M; McGrath MS
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):829-40. PubMed ID: 27071630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV: conformational camouflage.
    Jardetzky T
    Nature; 2002 Dec; 420(6916):623-4. PubMed ID: 12478278
    [No Abstract]   [Full Text] [Related]  

  • 27. Adaptation of HIV-1 to cells with low expression of the CCR5 coreceptor.
    Espy N; Pacheco B; Sodroski J
    Virology; 2017 Aug; 508():90-107. PubMed ID: 28521215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization.
    Hu Q; Trent JO; Tomaras GD; Wang Z; Murray JL; Conolly SM; Navenot JM; Barry AP; Greenberg ML; Peiper SC
    J Mol Biol; 2000 Sep; 302(2):359-75. PubMed ID: 10970739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccinology: A sweet cleft in HIV's armour.
    Sattentau QJ
    Nature; 2011 Dec; 480(7377):324-5. PubMed ID: 22170674
    [No Abstract]   [Full Text] [Related]  

  • 30. AIDS/HIV. Converging on an HIV vaccine.
    Korber B; Gnanakaran S
    Science; 2011 Sep; 333(6049):1589-90. PubMed ID: 21921189
    [No Abstract]   [Full Text] [Related]  

  • 31. Organization of cellular receptors into a nanoscale junction during HIV-1 adhesion.
    Dobrowsky TM; Daniels BR; Siliciano RF; Sun SX; Wirtz D
    PLoS Comput Biol; 2010 Jul; 6(7):e1000855. PubMed ID: 20657663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein.
    Stricher F; Huang CC; Descours A; Duquesnoy S; Combes O; Decker JM; Kwon YD; Lusso P; Shaw GM; Vita C; Kwong PD; Martin L
    J Mol Biol; 2008 Oct; 382(2):510-24. PubMed ID: 18619974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV gp120-induced interaction between CD4 and CCR5 requires cholesterol-rich microenvironments revealed by live cell fluorescence resonance energy transfer imaging.
    Yi L; Fang J; Isik N; Chim J; Jin T
    J Biol Chem; 2006 Nov; 281(46):35446-53. PubMed ID: 16963439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural dynamics of V3 loop with different electrostatics: implications on co-receptor recognition: a molecular dynamics study of HIV gp120.
    Chandramouli B; Chillemi G; Giombini E; Capobianchi MR; Rozera G; Desideri A
    J Biomol Struct Dyn; 2013 Apr; 31(4):403-13. PubMed ID: 22876913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
    Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
    FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly conserved beta16/beta17 beta-hairpin structure in human immunodeficiency virus type 1 YU2 gp120 is critical for CCR5 binding.
    Mechulam A; Cerutti M; Pugnière M; Missé D; Gajardo J; Roquet F; Robinson J; Veas F
    J Mol Med (Berl); 2005 Jul; 83(7):542-52. PubMed ID: 15905975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-based analysis of HIV-1 antibodies reveals structural constraints that may inform vaccine design.
    Tobin SC
    AIDS; 2015 Sep; 29(15):N13. PubMed ID: 26237101
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.
    Qiao Y; Man L; Qiu Z; Yang L; Sun Y; He Y
    Antiviral Res; 2016 Aug; 132():252-61. PubMed ID: 27387828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A functional model of the central epitope of the V3 loop of HIV-1 gp120 when complexed with antibodies].
    Shchelkanov MIu; Iaroslavtseva NG; Emel'ianov AV; Sakhuriia IB; Abélian AV; Verevochkin SV; Kozlov AP; Karamov EV
    Mol Biol (Mosk); 1998; 32(6):1062-74. PubMed ID: 9929887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.